Bayer backs out of Atara cell therapy deal
Dive Brief:
Bayer plans stop developing cancer cell therapies with Atara Biotherapeutics, informing the California biotech company that it will terminate a researc...
Mastering ADC Bioconjugation: From DAR Control to Efficient Free Payload Removal
Continue readingAdvertisement
Advertisement
Advertisement
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.